Figure 9From: PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritisPDL241 treatment reduced the severity of joint-related histopathological parameters in the rhesus CIA model. The histopathology score was based on a grading system described by Petit et al. [29]. Analyses were performed for (A) ‘all animal’ or (B) the ‘early CRP onset’ subgroup. CIA, collagen-induced arthritis; CRP, C-reactive protein.Back to article page